A Study On Prevalence Of Anxiety And Depression Among Cancer Patients: A Cross Sectional Study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 9, Pages 224-229
AbstractPeople who have been diagnosed with cancer have a significantly increased risk of suffering from depression and anxiety.The purpose of this research was to evaluate the levels of depression and anxiety that was found in cancer patients.
Material and Methods: Patients who had just been diagnosed with breast, colorectal, stomach, oesophageal, lung, or thyroid cancer and were planned for surgery, chemotherapy, radiotherapy, or combination therapy were evaluated as part of the study from the years 2020 to 2023. Ethical clearance was obtained and informed consent was obtained for initiation of study. Patients who have a previous diagnosis of a psychological condition were not allowed to participate in the trial. The size of the sample was determined to be 150 cases (based on an estimation of 30 percent anxiety or depression in cancer patients with a significance level of 0.05 and a standard deviation value of 0.20).
Results: During the course of the study, there were a total of 150 participants who had recently been diagnosed with breast, colorectal, stomach, oesophageal, lung, or thyroid cancer. Eighty-one (54%) patients had no clinical symptoms of anxiety, 44 (29.3%) mild anxiety, 25 (16.7%) with symptomatic anxiety and these rates were seen in 78 (52%), 40 (26.7%), 32 (21.3%) for depression, respectively.
Conclusion: Those suffering from cancers of the breast and stomach had the highest prevalence of anxiety and depression compared to patients suffering from other types of cancer.
- Article View: 6
- PDF Download: 16